| Literature DB >> 36193068 |
Qian Gao1,2, Xue-Dong Yin1,2, Fan Zhang3, Yi-Zhun Zhu4,5, Zhi-Ling Li1.
Abstract
Traditional Chinese medicine (TCM) has significantly contributed to protecting human health and promoting the progress of world civilization. A total of 2,711 TCMs are included in the 2020 version of the Chinese Pharmacopoeia, which is an integral part of the world's medical resources. Tu Youyou and her team discovered and purified artemisinin. And their contributions made the values and advantageous effects of TCM more and more recognized by the international community. There has been a lot of studies on TCM to treat diseases through antioxidant mechanisms, the reports on the new mechanisms beyond antioxidants of TCM has also increased year by year. Recently, many TCMs appear to have significant effects in regulating ferroptosis. Ferroptosis is an iron-dependent, non-apoptotic, regulated cell death characterized by intracellular lipid peroxide accumulation and oxidative membrane damage. Recently, accumulating studies have demonstrated that numerous organ injuries and pathophysiological process of many diseases are companied with ferroptosis, such as cancer, neurodegenerative disease, acute renal injury, arteriosclerosis, diabetes, and ischemia-reperfusion injury. This work mainly introduces dozens of TCMs that can regulate ferroptosis and their possible mechanisms and targets.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36193068 PMCID: PMC9526626 DOI: 10.1155/2022/4578381
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 7.310
Representative TCMs as Ferroptosis Regulators.
| TCMs or active pharmaceutical ingredients | Function | Possible mechanism of regulating Ferroptosis | Herb Chinese name |
|---|---|---|---|
| Artemisinin/Dihydro-artemisinin | Inducer | Inhibited the function of system xc− | Qinghao |
| Leonurine | Inhibitor | Upregulated the Nrf2/HO-1 signaling | Yimucao |
| Astragalus Membranaceus | Inducer | Down-regulated the expression GPX4 | Huangqi |
| Quercetin | Inhibitor | Activated system xc− by inhibiting ATF3 | Hupisu |
| Dendrobium/Erianin | Inducer | Upregulated the levels of intracellular ROS by Ca2+/CaM signaling pathway | Shihu |
| Curcuma longa L/curcumin | Inducer | Inhibited system xc− by Nrf2/HO-1 signaling pathway | Jianghuang |
| Epigallocatechin-3-gallate,EGCG | Inhibitor | Activated system xc− by inducing Nrf2 nucleus translocation | Biaomeishizi |
| Glycyrrhiza | Inhibitor | Upregulated the expression of GPX4 | Gancao |
| Magnolia officinalis/Honokiol, HNK | Inducer | Upregulated the levels of ROS | Guangyulan |
| Salvia miltiorrhiza Bge./Tanshinone IIA | Inducer | Inhibited the function of system xc− | Danshen |
| Inula japonica Thunb./1,6-o-o-diacetyl-britannilactone, OABL | Inhibitor | Upregulated the levels of GSH | Xuanfuhua |
| Curcumae rhizome/Beta-elemene | Inducer | Upregulated the levels of ROS | Ezhu |
The English and Chinese name of these TCMs comes from the Pharmacopoeia of the People's Republic of China (version 2020).
Figure 1Significant TCMs involved in ferroptosis and their targets. There are three main iron death pathways, including the Cystine-GSH-GPX4 axis, CoQ10/FSP1, and DHODH axis. The frame of this color “peach” is filled with TCMs that are ferroptosis inhibitors; the frame of “light blue” is filled with ferroptosis inducers.
Figure 2Ferroptosis has played an important role in multiple diseases, such as nervous system diseases, liver diseases, heart diseases, gastrointestinal diseases, lung diseases, kidney diseases, and breast diseases. TCM is engaged in the prevention and treatment of these diseases by regulating ferroptosis. Artemisinin derivatives:DHA, Artesunate; astragalus membranaceus derivatives: curculigoside, astragalus polysaccharide, astragaloside IV; glycyrrhiza derivatives: glycyrrhizin, echinatin; ajuga nipponensis: ajudecunoid C(ADC).